William Brady

William Brady has over 20 years of experience in the field of biotherapeutic design and antibody engineering. William is currently working at Trio Pharmaceuticals, Inc. as the Director of Biotherapeutic Design. Prior to this, they held positions at Systimmune, where they served as the Associate Director of Antibody Engineering, and Confidential, where they worked as a Technical Consultant. William also has experience working at companies such as Ambrx, Pfizer, Allozyne, Trubion Pharmaceuticals, Immunex/Amgen, X-cyte Therapies, and Darwin Molecular. Throughout their career, they have been involved in various aspects of antibody engineering, including humanization, optimization, re-formatting, and bi-specific design. William has also been responsible for the design, production, and validation of reagents for protein science. Additionally, they have led teams and supervised scientists, published research results, and implemented advanced technologies in their work.

William Brady attended the University of Washington from 1980 to 1984, where they obtained a Bachelor of Science degree in Microbiology & Immunology.